---
$id: https://graph.org.ai/products/commodity/51434801
$type: Product
source: UNSPSC
code: "51434801"
title: "Neldazosin"
class: "51434800"
classTitle: "Antihypertensive drugs, synthesized"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Neldazosin

**UNSPSC Code**: 51434801
**Class**: [Antihypertensive drugs, synthesized](Antihypertensive drugs, synthesized.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antihypertensive agent with the molecular formula C18H25N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G3E7RO42MB, chemically known as 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(3-hydroxybutyryl)piperazine but generally known as neldazosin, which bears US NIH Compound Identifier 65908. European Medicines Agency schedules Neldazosin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09184MIG. The term NELDAZOSIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). NELDAZOSIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule neldazosin under HS 29335995 and SITC 51576. As of Q4 2014, NELDAZOSIN remains the US FDA Preferred Term for this commodity. Neldazosin bears US NLM identifiers UMLS ID C1882042 and NCI Concept Code C66226. SMILES: O=C(N1CCN(CC1)c1nc2c(c(n1)N)cc(OC)c(OC)c2)CC(O)C.

